![Oral Zinc as a Novel Adjuvant and Sparing Therapy for Systemic Isotretinoin in Acne Vulgaris: A Preliminary Comparative Study – JCAD | The Journal of Clinical and Aesthetic Dermatology Oral Zinc as a Novel Adjuvant and Sparing Therapy for Systemic Isotretinoin in Acne Vulgaris: A Preliminary Comparative Study – JCAD | The Journal of Clinical and Aesthetic Dermatology](https://jcadonline.com/wp-content/uploads/Salah_Table1.gif)
Oral Zinc as a Novel Adjuvant and Sparing Therapy for Systemic Isotretinoin in Acne Vulgaris: A Preliminary Comparative Study – JCAD | The Journal of Clinical and Aesthetic Dermatology
![Oral Zinc as a Novel Adjuvant and Sparing Therapy for Systemic Isotretinoin in Acne Vulgaris: A Preliminary Comparative Study – JCAD | The Journal of Clinical and Aesthetic Dermatology Oral Zinc as a Novel Adjuvant and Sparing Therapy for Systemic Isotretinoin in Acne Vulgaris: A Preliminary Comparative Study – JCAD | The Journal of Clinical and Aesthetic Dermatology](https://jcadonline.com/wp-content/uploads/Salah_Figure1.jpg)
Oral Zinc as a Novel Adjuvant and Sparing Therapy for Systemic Isotretinoin in Acne Vulgaris: A Preliminary Comparative Study – JCAD | The Journal of Clinical and Aesthetic Dermatology
![Amitől rettegnek a betegek: izotretinoin (Roaccutan™) - Dr. Tamási Béla PhD | bőrgyógyászat & nemi gyógyászat Amitől rettegnek a betegek: izotretinoin (Roaccutan™) - Dr. Tamási Béla PhD | bőrgyógyászat & nemi gyógyászat](https://tamasibeladr.hu/wp-content/uploads/2020/04/acne-scar2.jpg)
Amitől rettegnek a betegek: izotretinoin (Roaccutan™) - Dr. Tamási Béla PhD | bőrgyógyászat & nemi gyógyászat
![Oral Zinc as a Novel Adjuvant and Sparing Therapy for Systemic Isotretinoin in Acne Vulgaris: A Preliminary Comparative Study – JCAD | The Journal of Clinical and Aesthetic Dermatology Oral Zinc as a Novel Adjuvant and Sparing Therapy for Systemic Isotretinoin in Acne Vulgaris: A Preliminary Comparative Study – JCAD | The Journal of Clinical and Aesthetic Dermatology](https://jcadonline.com/wp-content/uploads/Salah_Table1_cont.gif)